Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

The company has multiple deals in place that would give it a significant footprint in the U.S. pot market -- once it is fully legal.

Canopy Growth Announces Yet Another U.S. Acquisition

Aurora Cannabis

Cronos Group

Tilray Brands

Canaccord Genuity Corp released its cannabis market report indicating a 26% increase in revenue opportunities for US businesses, reaching up to $30 billion in revenue in 2022. The report also outlines a compelling value proposition for Multi-State-Operators (MSOs) even though cannabis equities continue to face headwinds despite positive fundamental performances.

Canaccord Genuity predicts 26% revenue increase for US cannabis market in 2022, says revenue likely to cross $30B

Is Canopy Growth Stock A Buy Or Sell Now? Why I'm Getting Bullish

The company expects to be profitable by the end of its current fiscal year, but analysts aren't convinced.

Analysts Are Losing Hope in Canopy Growth. Should Investors Ditch the Stock?

Evogene

Flora Growth Corp

Greenlane Holdings

HEXO Corp

High Tide

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

See Why a Slew of Pot Stocks Made the News This Week

Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar cannabis boom.

Insider Cannabis: Time to buy US cannabis stocks - New York's legal gray area - Deals, deals, deals

OrganiGram Holdings Inc.

Are Canadian Pot Stocks Ready To Rebound In Q4 2021? The post Top Canadian Cannabis Stocks To Buy Now? 2 LPs For Watchlist Today appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Cannabis Stocks To Buy Now? 2 LPs For Watchlist Today

SMITHS FALLS, ON, Oct. 22, 2021 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2022 ended September 30, 2021, before financial markets open on November 5, 2021. Following the release of its second quarter fiscal year 2022 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Mike Lee, EVP & CFO at 10:00 AM Eastern Time on November 5, 2021.

Canopy Growth to Report Q2 2022 Financial Results on November 5, 2021

Why Canopy Growth, Tilray, and Hexo Stocks Dropped

Canopy Growth Corporation (CGC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Canopy Growth Corporation (CGC) Moves 8.6% Higher: Will This Strength Last?

SNDL Inc.

New York and California have both ruled in favor of pro-cannabis policies. The future is looking green for cannabis stocks.

Cannabis Stocks: Why CGC, TLRY, SNDL, CRON Stocks Are Getting High Today

Canopy Growth Corp. (NASDAQ:CGC) shares are trading higher Tuesday along with other cannabis stocks. Canopy Growth closed up 8.6% at $14.34.

Canopy Growth Looks Like It's Ready To Break Out And Change Directions

This article was originally published on The Fresh Toast and appears here with permission. People are quitting their jobs left and right, and the cannabis industry is reaping many of these benefits.

Cannabis Jobs On The Rise: Here's What's Prompting A Surge In Marijuana Employment

Wana Brands founder Nancy Whiteman has been called the Martha Stewart of pot edibles, but she told MarketWatch she's been more inspired by socially conscious brands such as Warby Parker Inc. and Patagonia as she charts the next chapter for her company with fresh capital from Canadian cannabis company Canopy Growth Corp.

Cannabis Watch: Cannabis edibles maker Wana Brands looks to promote more social causes after $298 million up front payment from Canopy Growth

Anebulo Pharmaceuticals

Colgate-Palmolive

GrowGeneration Corp

Akerna Corp

Lexaria Bioscience

8 of the Hottest Cannabis Stocks Right Now

Cannabis stocks have taken a big hit in recent months. But the lower CGC stock falls, the more likely a Constellation Brands buyout becomes.

Canopy Growth Stock Pullback Makes It a Buyout Target

Today, investors in Canopy Growth and CGC stock are buying into this cannabis player heavily as the company announced a key acquisition. The post CGC Stock Alert: 7 Things to Know About the Latest Canopy Growth Deal appeared first on InvestorPlace.

CGC Stock Alert: 7 Things to Know About the Latest Canopy Growth Deal

Canopy Growth Corp. (NASDAQ:CGC) shares are trading higher Thursday after the company announced that it plans to acquire Wana Brands.  Canopy Growth stock was up 4.25% at $13.86 Thursday afternoon.

Will Canopy Growth Stock See A Bounce, Trend Change Soon?

Another acquisition agreement shows Canadian companies are positioning for a future legal U.S. market.

Why Tilray and Canopy Growth Were Among Rising Cannabis Stocks Today

Canopy Growth Corp (NASDAQ: CGC) is trading higher Thursday after the company announced that it plans to acquire Wana Brands. Wana manufactures and sells gummies in Colorado and licenses its intellectual property to partners, who manufacture, distribute and sell Wana's gummies across the U.S.

Why Canopy Growth Shares Are Moving Higher Today

Canopy Growth Corporation (TSX:WEED) (NASDAQ: CGC) acquired the right to buy Wana Brands, the number one cannabis edibles brand in the U.S. by market share, upon federal cannabis legalization. The cannabis giant confirmed Thursday it has signed definitive agreements for this arrangement with Mountain High Products, LLC, Wana Wellness, LLC, and The Cima Group, LLC (collectively Wana).

Canopy Growth Will Buy Wana Brands, The #1 Cannabis Edibles Brand In North America

The U.S.-listed shares of Canopy Growth Corp. CGC, +1.22% WEED, +1.22% rose 2.0% in prmarket trading Thursday, after the Canada-based cannabis company announced an agreement to buy Wana Brands, which the company says is the number one edibles brand in North America by market share. The deal will go into effect once THC becomes federally permissable in the U.S. The deal is structured as three separate option agreements, with Canopy making an upfront cash payment of $297.5 million as consideration for entering into the agreements.

Canopy Growth enters agreement to buy Wana Brands, with deal including cash payment of nearly $300 mln

Canada's Canopy Growth Corp said on Thursday it would buy weed gummies maker Wana Brands for $297.5 million, as the world's biggest pot producer looks to expand in the U.S. cannabis market.

Canopy eyes U.S. expansion with weed gummies maker Wana Brands' acquisition

Transaction Strengthens Canopy Growth's U.S. Ecosystem and Increases U.S. Cannabis Market Exposure Upon Federal Permissibility SMITHS FALLS, ON and BOULDER, Colo., Oct. 14, 2021 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED) (NASDAQ: CGC) and Mountain High Products, LLC, Wana Wellness, LLC and The Cima Group, LLC (collectively, "Wana" and each, a "Wana Entity") are pleased to announce that they have entered into definitive agreements (the "Agreements") providing Canopy Growth with the right, upon federal permissibility of THC in the U.S., to acquire 100% of the outstanding membership interests of Wana, the #1 cannabis edibles brand in North America by market share.

Canopy Growth Announces Plan to Acquire Wana Brands, the #1 Cannabis Edibles Brand in North America

These Marijuana Stocks Are Brining In More Attention From Potential Investors The post These Marijuana Stocks Have Investors Paying Close Attention Here's Why appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

News for Canopy Growth Stock (CGC)